The effect of fibrinolysis inhibitors on the ellagic acid activation of Hageman factor in the dog.
D000614:Aminocaproates / Q000494:pharmacology*; D000818:Animals; D007611:Aprotinin / Q000494:pharmacology*; D001780:Blood Coagulation Tests; D004285:Dogs; D005174:Factor XII / Q000037:antagonists & inhibitors*; D005342:Fibrinolysis / Q000187:drug effects; D005707:Gallic Acid / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D005898:Glass; D012825:Silicon; D012964:Sodium; D013997:Time Factors
D000614:Aminocaproates; D005707:Gallic Acid; D005174:Factor XII; D007611:Aprotinin; D012964:Sodium; D012825:Silicon